WINT
WINDTREE THERAPEUTICS INC /DE/
Key Financials
Net Income
$-1787000
↑ 91.2%
Operating Income
$-26139000
↓ 26.9%
Revenue
$198000
↑ 25.3%
Total Assets
$27.9M
↓ 14.0%
EPS (Diluted)
$-24.14
↓ 2588.7%
Shareholders' Equity
$10.0M
↑ 194.8%
Total Liabilities
$14.7M
↓ 49.3%
Operating Cash Flow
$-15402000.00
↓ 14.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| NT 10-K | 4/1/2026 | View on SEC |
| 8-K | 1/7/2026 | View on SEC |
| 8-K | 12/2/2025 | View on SEC |
| 424B3 | 11/21/2025 | View on SEC |
| 10-Q | 11/19/2025 | View on SEC |
| NT 10-Q | 11/14/2025 | View on SEC |
| 424B3 | 11/13/2025 | View on SEC |
| S-1 | 10/24/2025 | View on SEC |
| 8-K | 10/16/2025 | View on SEC |
| 8-K | 10/6/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | WINT |
| Company Name | WINDTREE THERAPEUTICS INC /DE/ |
| CIK | 946486 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 2154889300 |